Evidence map›Paper›PMID 38230318›Full record

ArticleCentral European journal of urology2023

Impact of outcomes and costs for implementation of robotic radical cystectomy with full intracorporeal urinary diversion.

Razvan George Rahota, Jean-Baptiste Beauval, Jean-Romain Gautier, Christophe Almeras, Valerie Garnault, Guillaume Loison, Ambroise Salin, Christophe Tollon, Guillaume Ploussard

Open access · greenAbstract read
In one paragraph

Article in Central European journal of urology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Razvan George RahotaDepartment of Urology, La Croix du Sud Hospital, Quint Fonsegrives, France.
Jean-Baptiste BeauvalDepartment of Urology, La Croix du Sud Hospital, Quint Fonsegrives, France.
Jean-Romain GautierDepartment of Urology, La Croix du Sud Hospital, Quint Fonsegrives, France.
Christophe AlmerasDepartment of Urology, La Croix du Sud Hospital, Quint Fonsegrives, France.
Valerie GarnaultDepartment of Public Health, PMSI, Ramsay Sante, France.
Guillaume LoisonDepartment of Urology, La Croix du Sud Hospital, Quint Fonsegrives, France.
Ambroise SalinDepartment of Urology, La Croix du Sud Hospital, Quint Fonsegrives, France.
Christophe TollonDepartment of Urology, La Croix du Sud Hospital, Quint Fonsegrives, France.
Guillaume PloussardDepartment of Urology, La Croix du Sud Hospital, Quint Fonsegrives, France.
Lyon Genou Centre Albert Trillat · FRGénérale de Santé · FRUniversity of Oradea · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Radical cystectomy (RC) remains a surgery with important morbidity despite technical advances. Our aim was to determine the impact on outcomes and costs of robot-assisted radical cystectomy (RARC) with full intracorporeal diversion. Material and methods: We retrospectively included 196 consecutive patients undergone RC for bladder cancer between 2017 and 2022. Comparisons were done between the open radical cystectomy (ORC; n = 166) and RARC with full intracorporeal diversion (n = 30) in the overall cohort and after matched pair analysis. Results: More neobladders were performed in the RARC group (40% vs 18.7%, p = 0.011). Peri-operative parameters continuously improved over time in the RARC cohort despite an increased proportion of elderly patients with higher comorbidity index. RARC patients had lower prolonged stay (33.3% vs 68.3%, p = 0.002), lower grade 1 complication rates (26.7% vs 53.3%, p = 0.016) and blood loss (185 vs 611 ml, p <0.001) than ORC patients. RARC was an independent favorable predictor for prolonged stay (OR 0.199) and complication (OR 0.334). Cost balance favored ORC, with an increase of hospitalization cost at 816 euros for RARC. Conclusions: After matching, RARC with full intracorporeal diversion was associated with improved outcomes and a moderated increase of post-operative costs mainly due to the use of robotic devices.

Indexed as

bladder cancercostenhanced recovery after surgeryradical cystectomyrobot

Identifiers

PMID38230318
PMCPMC10789279
OpenAlexW4390890661

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.